|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0015295,
umls-concept:C0021920,
umls-concept:C0029246,
umls-concept:C0033413,
umls-concept:C0040649,
umls-concept:C0086418,
umls-concept:C0205145,
umls-concept:C0439659,
umls-concept:C0678594,
umls-concept:C1332656,
umls-concept:C1519249,
umls-concept:C2348519
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1991-3-5
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The third component of human complement (C3) is a key molecule in the activation of the complement cascade. C3 cDNA fragments were used to identify seven cosmid clones that covered all but 1 kilobase pair (kb) of the C3 gene. The remainder of the gene was cloned by using the polymerase chain reaction. These clones were used to identify the intron/exon boundaries and to map the gene. The C3 gene is 42 kb in length and comprises 41 exons ranging in size from 52 to 213 base pairs (bp). The transcription start site was identified by primer extension, and approximately 1 kb of DNA upstream of this site was sequenced. Putative TATA and CAAT boxes were identified along with a number of regions that shared homology with known regulatory sequences. These include responsive elements for interferon-gamma, interleukin-6, nuclear factor kappa B, estrogen, glucocorticoids and thyroid hormone. Several of these agents have been shown to affect C3 synthesis and mRNA levels. The sizes of the exons in C3 were compared to those of C4 and alpha 2-macroglobulin (alpha 2M). Thirty-nine of 41 exons in C4 were found to be of similar size to the analogous ones in C3, and two-thirds of those in alpha 2M were also similarly sized, supporting the hypothesis that these genes arose from a common ancestor.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0006-2960
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
29
|
|
pubmed:volume |
30
|
|
pubmed:geneSymbol |
C3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1080-5
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:1703437-Amino Acid Sequence,
pubmed-meshheading:1703437-Base Sequence,
pubmed-meshheading:1703437-Biological Evolution,
pubmed-meshheading:1703437-Biological Factors,
pubmed-meshheading:1703437-Complement C3,
pubmed-meshheading:1703437-DNA,
pubmed-meshheading:1703437-Exons,
pubmed-meshheading:1703437-Hormones,
pubmed-meshheading:1703437-Humans,
pubmed-meshheading:1703437-Introns,
pubmed-meshheading:1703437-Molecular Sequence Data,
pubmed-meshheading:1703437-Promoter Regions, Genetic,
pubmed-meshheading:1703437-RNA, Messenger,
pubmed-meshheading:1703437-Sequence Homology, Nucleic Acid,
pubmed-meshheading:1703437-Structure-Activity Relationship,
pubmed-meshheading:1703437-TATA Box,
pubmed-meshheading:1703437-Transcription, Genetic,
pubmed-meshheading:1703437-alpha-Macroglobulins
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence.
|
|
pubmed:affiliation |
Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|
